ObjectiveTo develop safe ovarian stimulation methods to perform in vitro fertilization (IVF) in breast cancer patients who wish to preserve their fertility via embryo cryopreservation before chemotherapy.
The Women s Oncology Review Template
Write in a clean editor, then format for The Women s Oncology Review in one click — DocuGuru applies the official Taylor & Francis template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the The Women s Oncology Review format
The Women s Oncology Review is a peer-reviewed journal published by Taylor & Francis, covering Breast Cancer Treatment Studies, Ovarian cancer diagnosis and treatment, Cancer Treatment and Pharmacology.
| Publisher | Taylor & Francis |
|---|---|
| Reference style | Author–year (Chicago, T&F) Author–year — (Smith, 2023) in the text Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." The Women s Oncology Review 12 (3): 45–58.
Formats any DOI in The Women s Oncology Review style. No sign-up. |
| Publishes research in | Breast Cancer Treatment Studies Ovarian cancer diagnosis and treatment Cancer Treatment and Pharmacology Breast Lesions and Carcinomas Endometrial and Cervical Cancer Treatments |
| ISSN | 1473-3404 |
| h-index | 24 |
| i10-index | 46 |
| Total citations | 3,303 |
| Top institutions publishing here | Temple University |
| Journal website | www.tandfonline.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in The Women s Oncology Review per year
Citation impact of The Women s Oncology Review by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in The Women s Oncology Review
We hypothesized that immunoliposomes (ILs) that target epidermal growth factor receptor (EGFR) and/or its truncated variant EGFRvIII can be constructed to provide efficient intracellular drug delivery in tumor cells overexpressing these receptors. Monoclonal antibody fragments included Fab' fragments derived from C225, which binds both EGFR and EGFRvIII, or novel anti-EGFR scFv C10, which binds EGFR…
(2004). Vaginal radical trachelectomy: an oncologically safe fertility-preserving surgery. An updated series of 72 cases and review of the literature. The Women's Oncology Review: Vol. 4, No. 4, pp. 275-276.